PFO
AGN

Pathstone Family Office’s Allergan Inc AGN Stock Holding History

Pathstone Family Office’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-100
Closed -$21K – 138
2014
Q4 		$21K Hold
100
– – 0.07% 50
2014
Q3 		$18K Buy
+100
New +$16.6K 0.06% 151

Other funds holding AGN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return
ECM
Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return
HFS
HL Financial Services Louisville, Kentucky $6.5B AUM 9.56% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Pathstone Family Office's AGN Position: Q1 2015 in Review

Pathstone Family Office sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 100 shares — an estimated $21K sold.

Pathstone Family Office first reported a position in AGN in Q3 2014 and held it in 2 quarters. The position peaked at $21K in Q4 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • Pathstone Family Office reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • Pathstone Family Office sold 100 Allergan Inc shares in Q1 2015, an estimated $21K.
  • Pathstone Family Office first reported a position in Allergan Inc in Q3 2014 and held it in 2 quarters.
  • Pathstone Family Office's Allergan Inc position peaked at $21K in Q4 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Pathstone Family Office's 13F filing for Q1 2015, filed 1 May 2015.